CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands |
Total |
Common Stock
Class A Common Stock
|
Common Stock
Class B Common Stock
|
Additional Paid in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income |
Treasury Stock Amount |
| Beginning balance (in shares) at Dec. 31, 2021 |
|
407,781
|
393,014
|
|
|
|
|
| Beginning balance at Dec. 31, 2021 |
$ 1,678,528
|
$ 41
|
$ 39
|
$ 5,702,388
|
$ (3,753,814)
|
$ 36,488
|
$ (306,614)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
913
|
|
|
|
|
|
| Exercise of stock options |
1,770
|
|
|
1,770
|
|
|
|
| Stock-based compensation expense |
187,077
|
|
|
187,077
|
|
|
|
| Purchase of treasury stock (in shares) |
|
(793)
|
|
|
|
|
|
| Purchase of treasury stock |
(14,083)
|
|
|
|
|
|
(14,083)
|
| Restricted stock unit vesting (in shares) |
|
9,327
|
|
|
|
|
|
| Restricted stock unit vesting |
1
|
$ 1
|
|
|
|
|
|
| Net loss |
(467,693)
|
|
|
|
(467,693)
|
|
|
| Ending balance (in shares) at Mar. 31, 2022 |
|
417,228
|
393,014
|
|
|
|
|
| Ending balance at Mar. 31, 2022 |
1,385,600
|
$ 42
|
$ 39
|
5,891,235
|
(4,221,507)
|
36,488
|
(320,697)
|
| Beginning balance (in shares) at Dec. 31, 2021 |
|
407,781
|
393,014
|
|
|
|
|
| Beginning balance at Dec. 31, 2021 |
1,678,528
|
$ 41
|
$ 39
|
5,702,388
|
(3,753,814)
|
36,488
|
(306,614)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
| Equity consideration issued for acquisitions |
460
|
|
|
|
|
|
|
| Net loss |
(684,796)
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2022 |
|
448,022
|
393,014
|
|
|
|
|
| Ending balance at Jun. 30, 2022 |
1,763,884
|
$ 45
|
$ 39
|
6,490,012
|
(4,438,610)
|
36,488
|
(324,090)
|
| Beginning balance (in shares) at Mar. 31, 2022 |
|
417,228
|
393,014
|
|
|
|
|
| Beginning balance at Mar. 31, 2022 |
1,385,600
|
$ 42
|
$ 39
|
5,891,235
|
(4,221,507)
|
36,488
|
(320,697)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
902
|
|
|
|
|
|
| Exercise of stock options |
3,131
|
|
|
3,131
|
|
|
|
| Stock-based compensation expense |
135,521
|
|
|
135,521
|
|
|
|
| Equity consideration issued for acquisition (in shares) |
|
29,252
|
|
|
|
|
|
| Equity consideration issued for acquisitions |
460,128
|
$ 3
|
|
460,125
|
|
|
|
| Purchase of treasury stock (in shares) |
|
(254)
|
|
|
|
|
|
| Purchase of treasury stock |
(3,393)
|
|
|
|
|
|
(3,393)
|
| Restricted stock unit vesting (in shares) |
|
894
|
|
|
|
|
|
| Net loss |
(217,103)
|
|
|
|
(217,103)
|
|
|
| Ending balance (in shares) at Jun. 30, 2022 |
|
448,022
|
393,014
|
|
|
|
|
| Ending balance at Jun. 30, 2022 |
1,763,884
|
$ 45
|
$ 39
|
6,490,012
|
(4,438,610)
|
36,488
|
(324,090)
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
450,575
|
393,014
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
1,322,693
|
$ 45
|
$ 39
|
6,750,055
|
(5,131,801)
|
36,488
|
(332,133)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
701
|
|
|
|
|
|
| Exercise of stock options |
2,192
|
|
|
2,192
|
|
|
|
| Stock-based compensation expense |
117,400
|
|
|
117,400
|
|
|
|
| Purchase of treasury stock (in shares) |
|
(1,399)
|
|
|
|
|
|
| Purchase of treasury stock |
(27,358)
|
|
|
|
|
|
(27,358)
|
| Restricted stock unit vesting (in shares) |
|
11,757
|
|
|
|
|
|
| Restricted stock unit vesting |
1
|
$ 1
|
|
|
|
|
|
| Net loss |
(397,148)
|
|
|
|
(397,148)
|
|
|
| Ending balance (in shares) at Mar. 31, 2023 |
|
461,634
|
393,014
|
|
|
|
|
| Ending balance at Mar. 31, 2023 |
1,017,780
|
$ 46
|
$ 39
|
6,869,647
|
(5,528,949)
|
36,488
|
(359,491)
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
450,575
|
393,014
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
$ 1,322,693
|
$ 45
|
$ 39
|
6,750,055
|
(5,131,801)
|
36,488
|
(332,133)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
| Exercise of stock options (in shares) |
14,606
|
|
|
|
|
|
|
| Equity consideration issued for acquisitions |
$ 0
|
|
|
|
|
|
|
| Net loss |
(474,418)
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
463,257
|
393,014
|
|
|
|
|
| Ending balance at Jun. 30, 2023 |
1,018,491
|
$ 46
|
$ 39
|
6,961,454
|
(5,606,219)
|
36,488
|
(373,317)
|
| Beginning balance (in shares) at Mar. 31, 2023 |
|
461,634
|
393,014
|
|
|
|
|
| Beginning balance at Mar. 31, 2023 |
1,017,780
|
$ 46
|
$ 39
|
6,869,647
|
(5,528,949)
|
36,488
|
(359,491)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
284
|
|
|
|
|
|
| Exercise of stock options |
1,144
|
|
|
1,144
|
|
|
|
| Stock-based compensation expense |
89,193
|
|
|
89,193
|
|
|
|
| Shares issued for exercise of warrants (in shares) |
|
62
|
|
|
|
|
|
| Shares issued for exercise of warrants |
1,470
|
|
|
1,470
|
|
|
|
| Purchase of treasury stock (in shares) |
|
(587)
|
|
|
|
|
|
| Purchase of treasury stock |
(13,826)
|
|
|
|
|
|
(13,826)
|
| Restricted stock unit vesting (in shares) |
|
1,864
|
|
|
|
|
|
| Net loss |
(77,270)
|
|
|
|
(77,270)
|
|
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
463,257
|
393,014
|
|
|
|
|
| Ending balance at Jun. 30, 2023 |
$ 1,018,491
|
$ 46
|
$ 39
|
$ 6,961,454
|
$ (5,606,219)
|
$ 36,488
|
$ (373,317)
|